To explore the association of polymorphisms in the region of three neighboring genes TRIT1, MYCL1 and MFSD2A with risk and clinicopathological features of gastric cancer, 19 tagging SNPs in this region were genotyped using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry in a casecontrol study of 610 Chinese gastric cancer patients and 608 cancer-free controls. MFSD2A rs4233508 T>C CC genotype was associated with an increased risk of gastric cancer in younger patients and an increased risk of moderately/well-differentiated intestinal-type gastric cancer (adjusted odds ratio [OR], 1.74 and 1.50, respectively). TRIT1 rs11581557 T>G TG was associated with lymph node metastasis (TG versus TT/GG, adjusted OR, 1.64). MFSD2A rs12083239 GC genotype and TRIT1 rs2172362 or rs230310 homozygous genotype were associated with Lauren's classification (GC versus GG, adjusted OR, 1.69; GC versus GG/ CC, adjusted OR, 1.74) and tumor site (rs2172362: CC versus CT, adjusted OR, 1.71; CC/TT versus CT, adjusted OR, 1.62; rs230310: CC versus CT, adjusted OR, 1.75; CC/TT versus CT, adjusted OR, 1.67) of gastric cancer, respectively. One TRIT1 haplotype, CCGT, was associated with lymph node metastasis and tumor site of gastric cancer (CCGT versus TTTT, adjusted OR, 1.91 and 1.55). This is believed to be the first report that several tagging SNPs and haplotypes in TRIT1, MYCL1 and MFSD2A region are significantly associated with risk and clinicopathological features of gastric cancer in a Chinese population. The findings might be useful for risk assessment and prognosis prediction of gastric cancer.
Introduction
Gastric cancer is one of the leading causes of cancer-related death worldwide (1, 2) . In China, there are almost 300 000 deaths due to gastric cancer every year. Nearly 80% of patients are in advanced stage when diagnosed, and the average 5-year survival rate is <30% because of the high incidence of metastasis (3) . The etiology of gastric cancer is complicated and not fully understood. Cumulative evidence has shown that in addition to environmental risk factors, genetic factors play an important role in the development and progression of gastric cancer (4, 5) . As a third-generation genetic marker, single nucleotide polymorphism (SNP) is believed to be the most common genetic variation that might contribute to individual susceptibility to cancer and clinical outcome (6, 7) .
As a member of the myc proto-oncogene family, human MYCL1 is located on chromosome 1p34.2 with a genomic length of 6.59 kb, consisting of three exons and two introns. It was initially isolated from a human small-cell lung cancer cell line (8) . The protein encoded by MYCL1 is a nuclear phosphoprotein, heterodimerizes with partner protein Max and acts as transcription factor to control the expression of a specific set of target genes (9, 10) . MYCL1 has an important effect on the process of cell growth, differentiation and apoptosis (11, 12) , and is amplified and overexpressed in several malignancies (13) (14) (15) . MFSD2A and TRIT1 are the two neighboring genes of MYCL1. MFSD2A is 14.84 kb in length and consists of 14 exons. The protein encoded by the gene belongs to a large family of presumptive carbohydrate transporters with several transmembrane domains and plays an important role in placenta morphogenesis and adaptive thermogenesis (16, 17) . MFSD2A is also a lung tumor-suppressor gene that modulates the cell cycle and matrix attachment (18) . TRIT1 is 42.48 kb in length and its product tRNA isopentenyltransferase is involved in post-transcriptional modifications of tRNA molecules; therefore, TRIT1 is believed to be important in ensuring correct protein synthesis (19) . In addition, TRIT1 is also a candidate human lung cancer suppressor gene (20) .
TRIT1, MYCL1 and MFSD2A are the three neighboring genes located on chromosome 1p34.2 and span 42.48, 6 .59 and 14.84 kb, respectively. According to the NCBI SNP database (http://www.ncbi. nlm.nih.gov/snp, 26 January 2013, date last accessed), there are many potential functional SNPs [e.g. non-synonymous SNPs promoter SNPs and SNPs located in 3′ and 5′ untranslated region] identified in other ethnic populations within the region from 20 kb upstream of TRIT1 to 20 kb downstream of MFSD2A. An increasing number of studies have revealed that genetic variants in the TRIT1, MYCL1 and MFSD2A region may affect some particular types of cancer, including gastric cancer (21) (22) (23) (24) (25) . However, most studies have only focused on a few individual SNPs, such as rs3134613 and rs3738671. In the present study, 19 tagging SNPs (tSNPs) were selected and their relationships with the risk and clinicopathological features of gastric cancer in a southeast Chinese population were investigated to evaluate further the role of genetic variants in gastric cancer.
Materials and methods

Study participants
This hospital-based case-control study consisted of 610 gastric cancer patients and 608 cancer-free controls. All patients were genetically unrelated ethnic Han Chinese and were from Fuzhou city and surrounding regions in southeast China. Those who had previously received chemotherapy or radiotherapy or had a family history of cancer were excluded. Family history of cancer was defined as any self-reported cancer in first-degree relatives (parents, siblings or children).
Patients were consecutively recruited at the Affiliated Hospital of Fujian Medical University between October 2007 and December 2009, with a response rate of 88.7%. The diagnosis of every case was histopathologically confirmed by two pathologists independently after surgery. Clinicopathological data were obtained from the medical records of all the gastric cancer patients. Tumor histological classification of gastric cancer was performed according to the criteria by Lauren (26) . Tumor differentiation was classified according to the World Health Organization classification.
The control group was selected randomly from healthy individuals who visited the same hospitals for regular health checkups, with a response rate of 91.6%, during the same period when the cases were recruited. Persons with self-reported history of any cancer or other major diseases were excluded. The controls were frequency matched to the cases on age (±5 years), sex and residential area (urban or rural). Informed consent was obtained from each participant before sample collection. The study was approved by the Institutional Review Board of Fujian Medical University.
TRIT1, MYCL1, MFSD2A and gastric cancer
Sample collection, DNA isolation, SNP selection and genotyping Five-milliliter peripheral blood samples were collected from each cancer-free control at the time of recruitment and normal gastric mucosa adjacent to the tumor tissue (distance > 5 cm) was collected from each patient shortly after surgery. Genomic DNA was extracted using the Qiagen DNA Isolation Kit (Germany Genotyping was performed by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry on a Sequenom MassARRAY iPLEX platform (Sequenom company, USA). Primers for amplification and extension were designed using the Sequenom Assay Design program, and reaction conditions were set according to the manufacturer's instructions. Information on primers is available upon request. For quality control, two duplicated samples and two no-template controls in each 96-well plate were included to assess the reproducibility and accuracy. All genotyping results were reviewed independently by two laboratory staff, without knowing the patients' case/control status. The average genotype call rate for these SNPs was 99.4% and results for all duplicated samples showed 100% concordance.
Statistical analysis
For each polymorphism, deviation of genotype frequencies in controls from those expected under Hardy-Weinberg equilibrium (HWE) was assessed using χ 2 tests. Haploview 4.2 software was used to define haplotype blocks according to the method of Gabriel et al. (27) and to calculate LD among polymorphisms. Using software language R, PHASE 2.0 Bayesian algorithm (http://stephenslab.uchicago. edu/software.html, 26 January 2013, date last accessed) was used to infer haplotypes and their frequencies based on the observed genotypes. The Haplo Stats program (http://mayoresearch.mayo.edu/mayo/research/biostat/splusfunctions.cfm, 26 January 2013, date last accessed), a score test based on generalized linear models, was also used to perform global and haplotype-specific tests for associations.
A χ 2 test was used to examine differences in the distributions of genotype and haplotype between cases and controls. The risk of gastric cancer associated with genotypes or haplotypes was estimated by calculating odds ratios (ORs) and 95% confidence intervals (CIs) with unconditional logistic regression analysis. Age and sex were included for multivariate adjustment. In addition to the overall association analysis, we also performed stratified analyses by age, sex and clinicopathological parameters such as tumor site, Lauren's classification, tumor differentiation and lymph node status. To reduce the potential of spurious findings due to multiple testing, false discovery rate correction according to the Hochberg and Benjamini method (28,29) was applied in association analyses. Power calculation was performed using the power and sample size software PS, version 3.0.7 (30) .
All statistical analyses were performed using the software package SPSS version 17.0 (SPSS, Chicago, IL, USA). All tests were two sided, and P < 0.05 was considered statistically significant.
Results
Characteristics of the study population
Selected characteristics of the study participants are summarized (data not shown). Briefly, there was no significant difference in age (t test, P = 0.618) or sex (χ 2 test, P = 0.927) between the case and the control groups. According to Lauren's histological classification, of all the gastric cancer cases, 490 were intestinal type (80.3%), 107 were diffuse type (17.5%) and 13 were indefinite type (2.2%). 490 intestinaltype cases were further subdivided into poorly (41.8%), moderately (54.1%) and well-differentiated (4.1%) gastric cancer. Lymph node metastasis was detected in 441 (72.3%) patients.
Associations between individual SNPs and risk of gastric cancer
Primary details of 19 tSNPs and allele frequencies are listed in Table I . In our cancer-free controls, most SNPs were in agreement with HWE and MAFs were similar to those published for the Chinese population in the dbSNP database (http://www.ncbi.nlm.nih.gov/snp, 26 January 2013, date last accessed). However, SNP rs16826649 deviated from HWE (P < 0.05) and was abandoned in the subsequent analysis. In addition, we found that there was a significant difference in MAF for SNP rs3134615 between the cases (0.025) and the controls (0.047) (P = 0.004), although both values in our study population were lower than that published in the dbSNP database for the Chinese Han population (0.093). We investigated the associations between all tested SNPs and overall gastric cancer risk under five genetic models (codominant, dominant, recessive, additive and overdominant models). As shown in Table II , there was a marginally significant difference in genotype distribution of rs4233508 between the cases and the controls (P = 0.049). Unconditional logistic regression analysis revealed that individuals carrying rs4233508 variant homozygous CC genotype had a significantly increased risk of gastric cancer (adjusted OR, 1.35; 95% CI, 1.04-1.77; P = 0.026) compared with T allele (TT/TC genotype) carriers under the recessive model, and this significance remained after false discovery rate adjustment (P = 0.027). In addition, another SNP, rs3134615 GT/TT genotype, was associated with a reduced gastric cancer risk compared with GG genotype (adjusted OR, 0.52; 95% CI, 0.33-0.83; P = 0.006). However, this protective effect was not convincing because the frequency of GT/TT genotype in our population was too low (5% for cases, 9% for controls). No other SNPs were associated with the overall risk of gastric cancer (data not shown).
Further stratified analyses by selected variables were performed to evaluate the associations of these SNPs with gastric cancer risk. As shown in Table III Figure 1 shows the LD structure of the TRIT1, MYCL1 and MFSD2A region. Five haplotype blocks were constructed, each containing the following SNPs: block 1: rs1999573, rs11576724 and rs6600301; block 2: rs2172362, rs230310, rs11581557 and rs761164; block 3: rs3134613 and rs7548524; block 4: rs4233508, rs6676052 and rs3103778; block5: rs11207227 and rs12072696. Haplotypes and their frequencies for each block were inferred by PHASE 2.0 programs based on the observed genotypes. For statistical consideration, we ignored all haplotypes with a frequency <0.05. There were no statistically significant differences in haplotype distributions between cases and controls by χ 2 test and global score test (data not shown). Haplotypes that exceeded 100 in amount were used to perform further stratified analyses according to selected clinicopathological features. Data are listed in Table V . Block 2 CCGT haplotype conferred a higher risk for development of lymph node metastasis, compared with the most common haplotype TTTT (adjusted OR, 1.91; 95% CI, 1.37-2.71); block 2 CCGT and block 5 CC haplotypes conferred a higher risk of development of cardiac gastric cancer rather than noncardiac gastric cancer, compared with the most common haplotype TTTT and CT in the respective blocks (adjusted OR, 1.55, 95% CI, 1.16-2.11; adjusted OR, 1.65, 95% CI, 1.14-2.39, respectively). These results remained significant after false discovery rate correction for multiple testing. No other haplotypes were associated with Lauren's classification or tumor differentiation (data not shown).
67). No other SNPs were associated with clinicopathological characteristics of the tumors (data not shown).
Presence of haplotype related to clinicopathological features
Discussion
In this hospital-based case-control study, we demonstrated that genetic polymorphisms in the region of three neighboring genes, TRIT1, MYCL1 and MFSD2A, were associated with the risk and clinicopathological features of gastric cancer. The evidence for this was as follows: MFSD2A rs4233508 T>C CC genotype was associated with an increased risk of gastric cancer in younger patients and an increased risk of moderately/well-differentiated intestinal-type gastric cancer; rs11581557, rs12083239 and rs2172362 or rs230310 were associated with lymph node metastasis, Lauren's classification and tumor site, respectively; and the presence of a haplotype was related to lymph node metastasis and tumor site in gastric cancer.
Until now, only Spinola et al. (22) have systematically and intensively studied gene polymorphisms in this region in lung cancer. Their results suggest that SNPs in an identified 106 kb LD block affect lung cancer survival in Italian and Norway patients. Furthermore, they also found that SNPs allelic frequencies vary among different ethnic populations, as seen in the NCBI SNP database, which may be due to genetic drift, population growth, admixture and natural selection (31) . As a result of this, the SNPs included in our study were different from those included in the study of Spinola et al. (22) and many of them even have been studied for the first time.
In this study, we found that carriers with CC genotype of a promoter SNP rs4233508 in MFSD2A were susceptible to moderately/well-differentiated intestinal-type gastric cancer and were associated with an increased risk in young individuals (age ≤60 years). MFSD2A is 14.8 kb in length, encoding a carbohydrate transporter with 12 α-helical transmembrane domains, which is a lung tumor-suppressor gene modulating cell cycle and matrix attachment (18) . Colombo et al. (32) have analyzed three SNPs (rs3131703, rs12072037 and rs3738668) in the MFSD2A 5′-regulatory region and have found that SNP rs12072037 modulates MFSD2A promoter activity and might affect MFSD2A expression in normal lung and lung tumors. Whether the three SNPs affect the development and progress of gastric cancer, or the risk effect of rs4233508 is influenced by the three SNPs or other linked, untyped variants, is still unknown and warrants further investigation. In addition, our result showed that the T allele of rs3134615, a SNP located in the 3′ untranslated region of MYCL1 gene, seemed to play a protective role in susceptibility to gastric cancer (GT/TT versus GG, OR, 0.52, P = 0.006), which differed from the result in small-cell lung cancer reported by Xiong et al. (33) . The latter have found that rs3134615 lies within the micro-RNA hsa-miR-1827 complementary site and rs3134615 G>T change resulted in altered regulation of MYCL1 expression. The T allele was associated with a significantly increased risk of small-cell lung cancer because its binding with has-miR-1827 was disrupted and MYCL1 expression may have been upregulated. With the same case-control design in Chinese population, the role of rs3134615 T allele seemed to differ between small-cell lung cancer and gastric cancer. This may reflect the tissue-specific risk of rs3134615, and more association studies with larger samples and functional analyses might be needed to reveal its real role in different types of cancer.
We also found associations between several individual SNPs in the TRIT1, MYCL1 and MFSD2A region and some clinicopathological features. TG genotype of TRIT1 intronic SNP rs11581557 (T>G) conferred an increased risk of lymph node metastasis and patients with TRIT1 upstream SNP rs2172362 or TRIT1 intronic SNP rs230310 homozygous genotype were more prone to develop cardiac than noncardiac gastric cancer. It is believed that a set of potential functional SNPs may be selected and harbored in specific conserved regions of the genome because of evolutionary pressure (34) . The short distance among the three positive SNPs seemed to be consistent with this phenomenon. The three variants are non-coding SNPs and they did not directly lead to protein alteration, and thus, their risk effects might have been due to their influence on transcriptional regulation, alternative splicing or messenger RNA stability (35) (36) (37) . However, we could not exclude the possibility of another nearby real causal locus in the LD model with these SNPs. Further studies need to be conducted to identify true causal polymorphic genetic elements. Additionally, rs12083239 GC genotype significantly increased risk of diffuse-type gastric cancer compared with GG/CC genotype (OR, 1.74). rs12083239 is an intergenic SNP located between MFSD2A and its adjacent downstream gene CAP1. Based on HapMap data, rs12083239 is not in LD block with neighboring genes, so its risk effect is unlikely to be explained by nearby functional genetic variants. The MAPPER platform (http:// mapper.chip.org, 26 January 2013, date last accessed) was used to test whether rs12083239 was located in a putative transcription factor binding site; however, no useful information was obtained. Therefore, our hypothesis that rs12083239 may play a role in long-range transcriptional regulation is undetermined. Nevertheless, we still believe that these positively associated SNPs that we found in the intron or intergene region may be helpful to elucidate the mechanisms involved in development and progression of gastric cancer.
In an association study of complex polygenic diseases such as gastric cancer, haplotype analysis might provide more statistical power than individual SNP analysis (38) . In this study, we further investigated the combined effect of multiple loci by haplotype analysis. In haplotype block 2 including rs2172362, rs230310, rs11581557 and rs761164, a TRIT1 CCGT haplotype conferred a higher risk of lymph node metastasis compared with the common haplotype TTTT (OR, 1.91). This strong statistical significance might have been partly due to the effect of SNP rs11581557. Lymph node metastasis reflects a patient's poor prognosis. We supposed that the positive-associated haplotype or genotype might have conferred on cancer cells a more aggressive phenotype and metastatic potential. Another finding was that in block 5 including rs11207227 and rs12072696, a MFSD2A CC haplotype conferred a higher risk of developing gastric cardiac rather than non-cardiac cancer, compared with the common haplotype CT (OR, 1.65). However, in individual analysis, both SNPs showed no effect, which reflects the complex interactions among multivariants.
Our study had several strengths. First, selection bias may have been minimized by matching age, gender, ethnicity and residential area between the case and the control groups. Second, with the current sample size, we had sufficient power (>80%) at a significance level of 0.05 to detect an association of OR ≥ 1.28 for each tSNP we TRIT1, MYCL1, MFSD2A and gastric cancer selected. However, one limitation in this study should be addressed. Reliable data on Helicobacter pylori infection were not available for all participants; therefore, it was difficult to adjust the potential confounding bias of H. pylori infection. This limitation should be overcome as the study population is increased. Moreover, the potential interaction between genes and H. pylori infection should be evaluated in the future. Next, we will investigate the expression of TRIT1 and MFSD2A in gastric cancer and/or gastric mucosa to evaluate the observed associations in terms of TRIT1 and/or MFSD2A gene functions. Also, the association of the polymorphisms with survival in gastric cancer patients needs to be explored.
In summary, as far as we are aware, our study provides the first report that some representative tSNPs and haplotypes in the TRIT1, MYCL1 and MFSD2A region are significantly associated with the development and progression of gastric cancer in a Chinese population. Several genetic elements, such as a promoter SNP rs4233508 and a TRIT1 haplotype CCGT, might be potential biomarkers to predict an individual's risk and patient prognosis. Nevertheless, our results should be validated in future studies with a larger sample size in different populations and functional analysis is needed to investigate the underlying molecular mechanisms. 
